1-Adamsadvitors, mauricevhector,allen.H.Reppe, cerebrovascular disease. Principle of Neurology. 2009; 511-2.
2-Werner H, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti,D, Larrue V, et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med 2008;359:1317- 29:1317-29.
3-Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J 1965:14:61-5.
4-Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome.
Stroke 2004 Jun;35(6):e156-8.
5-Dávalos A, Ricart W, Gonzalez-Huix F,
Soler S,
Marrugat J,
Molins A, et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996;27(6):1028–32.
6-Franch-Arcas G. The meaning of hypoalbuminemia in clinical practice. Clin Nutr 2001;20:265–9.
7-Belayev L, Pinard E, Nallet H,
Seylaz J,
Liu Y,
Riyamongkol P, et al. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke 2002;33(4):1077–84.
8-Belayev L, Liu Y, Zhao W,
Busto R,
Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001;32(2):553–60
9-Reinhart WH, Nagy C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 1995;25(7):523–8.
10-Halliwell B. Albumin--an important extracellular antioxidant? Biochem Pharmacol 1998;37(4):569–71.
11-Hallenbeck JM, Dutka AJ, Tanishima T,
Kochanek PM,
Kumaroo KK,
Thompson CB, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986;17(2):246–53.
12-Belayev L, Busto R, Zhao W,
Clemens JA,
Ginsberg MD. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg 1997;87(4):595–601
13-Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994;140(10):876-88.
14-Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and read mission. Arch Intern Med 1992;152(1):125-30.
15-Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A. Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr 2007;61(11):1318-22.
17-
Belayev L,
Liu Y,
Zhao W,
Busto R,
Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderat doses and with a broad therapeutic window. Stroke 2001;32(2):553-60.
18-
Gillum RF. Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites. J Natl Med Assoc 2000;92(1):3-9.
19-Cho YM, Choi IS, Bian RX, Kim JH, Han JY, Lee SG. Serum albumin at admission for prediction of functional outcome in ischemic stroke patients. Neurol Sci 2008;29(6):445–9.
)